Genetics, pathogenesis and clinical interventions in type 1 diabetes (original) (raw)

• Anderson, M. S. & Bluestone, J. A. The NOD mouse: a model of immune dysregulation. Annu. Rev. Immunol. 23, 447–485 (2005)
  Article CAS PubMed Google Scholar
• Vauzelle-Kervroedan, F. et al. Analysis of mortality in French diabetic patients from death certificates: a comparative study. Diabete Metab. 25, 404–411 (1999)
  CAS PubMed Google Scholar
• Maahs, D. M. & Rewers, M. Editorial: mortality and renal disease in type 1 diabetes mellitus—progress made, more to be done. J. Clin. Endocrinol. Metab. 91, 3757–3759 (2006)
  Article PubMed CAS Google Scholar
• Steffes, M. W. et al. (EDIC Research Group). Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study. J. Am. Med. Assoc. 290, 2159–2167 (2003)
  Article CAS Google Scholar
• Harjutsalo, V., Sjoberg, L. & Tuomilehto, J. Time trends in the incidence of type 1 diabetes in Finnish children: a cohort study. Lancet 371, 1777–1782 (2008)
  PubMed Google Scholar
• Lorenzen, T., Pociot, F., Hougaard, P. & Nerup, J. Long-term risk of IDDM in first-degree relatives of patients with IDDM. Diabetology 37, 321–327 (1994)
  Article CAS Google Scholar
• Mordes, J. P. et al. The BB/Wor rat and the balance hypothesis of autoimmunity. Diabetes Metab. Rev. 12, 103–109 (1996)
  Article CAS PubMed Google Scholar
• Makino, S. et al. Breeding of a non-obese, diabetic strain of mice. Exp. Anim. 29, 1–13 (1980)
  Article CAS Google Scholar
• DiLorenzo, T. P. & Serreze, D. V. The good turned ugly: immunopathogenic basis for diabetogenic CD8+ T cells in NOD mice. Immunol. Rev. 204, 250–263 (2005)
  Article CAS PubMed Google Scholar
• Burton, A. R. et al. On the pathogenicity of autoantigen-specific T-cell receptors. Diabetes 57, 1321–1330 (2008)
  Article CAS PubMed Google Scholar
• Han, B. et al. Developmental control of CD8 T cell-avidity maturation in autoimmune diabetes. J. Clin. Invest. 115, 1879–1887 (2005)
  Article CAS PubMed PubMed Central Google Scholar
• Serreze, D. V. et al. B lymphocytes are critical antigen-presenting cells for the initiation of T cell-mediated autoimmune diabetes in nonobese diabetic mice. J. Immunol. 161, 3912–3918 (1998)
  CAS PubMed Google Scholar
• Greeley, S. A. et al. Elimination of maternally transmitted autoantibodies prevents diabetes in nonobese diabetic mice. Nature Med. 8, 399–402 (2002)
  Article CAS PubMed Google Scholar
• Hu, C. Y. et al. Treatment with CD20-specific antibody prevents and reverses autoimmune diabetes in mice. J. Clin. Invest. 117, 3857–3867 (2007)
  Article CAS PubMed PubMed Central Google Scholar
• Zipris, D. et al. TLR9-signaling pathways are involved in Kilham rat virus-induced autoimmune diabetes in the biobreeding diabetes-resistant rat. J. Immunol. 178, 693–701 (2007)
  Article CAS PubMed Google Scholar
• Devendra, D. et al. Interferon-α as a mediator of polyinosinic:polycytidylic acid-induced type 1 diabetes. Diabetes 54, 2549–2556 (2005)
  Article CAS PubMed Google Scholar
• Concannon, P., Rich, S. S. & Nepom, G. T. Genetics of type 1A diabetes. N. Engl. J. Med. 360, 1646–1654 (2009)
  Article CAS PubMed Google Scholar
• Wicker, L. S. et al. Type 1 diabetes genes and pathways shared by humans and NOD mice. J. Autoimmun. 25 (Suppl.). 29–33 (2005)
  Article CAS PubMed ADS Google Scholar
• Turley, S. et al. Physiological beta cell death triggers priming of self-reactive T cells by dendritic cells in a type-1 diabetes model. J. Exp. Med. 198, 1527–1537 (2003)
  Article CAS PubMed PubMed Central Google Scholar
• Lieberman, S. M. & DiLorenzo, T. P. A comprehensive guide to antibody and T-cell responses in type 1 diabetes. Tissue Antigens 62, 359–377 (2003)
  Article CAS PubMed Google Scholar
• Medarova, Z. et al. In vivo imaging of a diabetogenic CD8+ T cell response during type 1 diabetes progression. Magn. Reson. Med. 59, 712–720 (2008)
  Article PubMed Google Scholar
• Lennon, G. P. et al. T cell islet accumulation in type 1 diabetes is a tightly regulated, cell-autonomous event. Immunity 31, 643–653 (2009)
  Article CAS PubMed PubMed Central Google Scholar
• Vafiadis, P. et al. Insulin expression in human thymus is modulated by INS VNTR alleles at the IDDM2 locus. Nature Genet. 15, 289–292 (1997)
  Article CAS PubMed Google Scholar
• Pugliese, A. et al. The insulin gene is transcribed in the human thymus and transcription levels correlate with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type I diabetes. Nature Genet. 15, 293–297 (1997)
  Article CAS PubMed Google Scholar
• Gardner, J. M., Fletcher, A. L., Anderson, M. S. & Turley, S. J. AIRE in the thymus and beyond. Curr. Opin. Immunol. 21, 582–589 (2009)
  Article CAS PubMed PubMed Central Google Scholar
• Kobayashi, M. et al. Conserved T cell receptor alpha-chain induces insulin autoantibodies. Proc. Natl Acad. Sci. USA 105, 10090–10094 (2008)
  Article ADS CAS PubMed PubMed Central Google Scholar
• Erlich, H. et al. HLA DR-DQ haplotypes and genotypes and type 1 diabetes risk: analysis of the Type 1 Diabetes Genetics Consortium families. Diabetes 57, 1084–1092 (2008)
  Article CAS PubMed Google Scholar
• Dotta, F. et al. Coxsackie B4 virus infection of beta cells and natural killer cell insulitis in recent-onset type 1 diabetic patients. Proc. Natl Acad. Sci. USA 104, 5115–5120 (2007)
  Article ADS CAS PubMed PubMed Central Google Scholar
• Gianani, R. et al. Dimorphic histopathology of long-standing childhood-onset diabetes. Diabetologia 53 (4). 690–698 (2010)
  Article CAS PubMed Google Scholar
• Itoh, N. et al. Mononuclear cell infiltration and its relation to the expression of major histocompatibility complex antigens and adhesion molecules in pancreas biopsy specimens from newly diagnosed insulin-dependent diabetes mellitus patients. J. Clin. Invest. 92, 2313–2322 (1993)
  Article CAS PubMed PubMed Central Google Scholar
• Willcox, A. et al. Analysis of islet inflammation in human type 1 diabetes. Clin. Exp. Immunol. 155, 173–181 (2009)
  Article CAS PubMed PubMed Central Google Scholar
• Esensten, J. H., Lee, M. R., Glimcher, L. H. & Bluestone, J. A. T-bet-deficient NOD mice are protected from diabetes due to defects in both T cell and innate immune system function. J. Immunol. 183, 75–82 (2009)
  Article CAS PubMed Google Scholar
• Bending, D. et al. Highly purified Th17 cells from BDC2.5NOD mice convert into Th1-like cells in NOD/SCID recipient mice. J. Clin. Invest. 119 (3), 565–572 (2009)
  Article CAS PubMed PubMed Central Google Scholar
• Ogasawara, K. et al. Impairment of NK cell function by NKG2D modulation in NOD mice. Immunity 18, 41–51 (2003)
  Article CAS PubMed Google Scholar
• Feuerer, M. et al. How punctual ablation of regulatory T cells unleashes an autoimmune lesion within the pancreatic islets. Immunity 31, 654–664 (2009)
  Article CAS PubMed PubMed Central Google Scholar
• Wong, F. S. et al. Investigation of the role of B-cells in type 1 diabetes in the NOD mouse. Diabetes 53, 2581–2587 (2004)
  Article CAS PubMed Google Scholar
• Xiu, Y. et al. B lymphocyte depletion by CD20 monoclonal antibody prevents diabetes in nonobese diabetic mice despite isotype-specific differences in Fc gamma R effector functions. J. Immunol. 180, 2863–2875 (2008)
  Article CAS PubMed Google Scholar
• Boni-Schnetzler, M. et al. Increased interleukin (IL)-1beta messenger ribonucleic acid expression in beta -cells of individuals with type 2 diabetes and regulation of IL-1beta in human islets by glucose and autostimulation. J. Clin. Endocrinol. Metab. 93, 4065–4074 (2008)
  Article PubMed PubMed Central CAS Google Scholar
• Koulmanda, M. et al. Modification of adverse inflammation is required to cure new-onset type 1 diabetic hosts. Proc. Natl Acad. Sci. USA 104, 13074–13079 (2007)
  Article ADS CAS PubMed PubMed Central Google Scholar
• Feuerer, M., Hill, J. A., Mathis, D. & Benoist, C. Foxp3+ regulatory T cells: differentiation, specification, subphenotypes. Nature Immunol. 10, 689–695 (2009)
  Article CAS Google Scholar
• Bacchetta, R. et al. Defective regulatory and effector T cell functions in patients with FOXP3 mutations. J. Clin. Invest. 116, 1713–1722 (2006)
  Article CAS PubMed PubMed Central Google Scholar
• Tang, Q. & Bluestone, J. A. The Foxp3+ regulatory T cell: a jack of all trades, master of regulation. Nature Immunol. 9, 339–344 (2008)
  Article CAS Google Scholar
• Winer, S. et al. Normalization of obesity-associated insulin resistance through immunotherapy. Nature Med. 15, 921–929 (2009)
  Article CAS PubMed Google Scholar
• Feuerer, M. et al. Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nature Med. 15, 930–939 (2009)
  Article CAS PubMed Google Scholar
• Yan, Z., Garg, S. K., Kipnis, J. & Banerjee, R. Extracellular redox modulation by regulatory T cells. Nature Chem. Biol. 5, 721–723 (2009)
  Article CAS Google Scholar
• Tang, Q. et al. Central role of a defective IL-2 production in triggering islet autoimmune destruction. Immunity 28, 687–697 (2008)
  Article CAS PubMed PubMed Central Google Scholar
• Zhou, X. et al. Foxp3 instability leads to the generation of pathogenic memory T cells in vivo . Nat. Immun. 10, 1000–1007 (2009)
  Article CAS Google Scholar
• Schneider, A. et al. The effector T cells of diabetic subjects are resistant to regulation via CD4+ FOXP3+ regulatory T cells. J. Immunol. 181, 7350–7355 (2008)
  Article CAS PubMed Google Scholar
• D'Alise, A. M. et al. The defect in T-cell regulation in NOD mice is an effect on the T-cell effectors. Proc. Natl Acad. Sci. USA 105, 19857–19862 (2008)
  Article ADS CAS PubMed PubMed Central Google Scholar
• Qin, H. Y. & Singh, B. BCG vaccination prevents insulin-dependent diabetes mellitus (IDDM) in NOD mice after disease acceleration with cyclophosphamide. J. Autoimmun. 10, 271–278 (1997)
  Article CAS PubMed Google Scholar
• Wen, L. et al. Innate immunity and intestinal microbiota in the development of type 1 diabetes. Nature 455, 1109–1113 (2008)
  Article ADS CAS PubMed PubMed Central Google Scholar
• Weintrob, N. et al. Type 1 diabetes environmental factors and correspondence analysis of HLA class II genes in the Yemenite Jewish community in Israel. Diabetes Care 24, 650–653 (2001)
  Article CAS PubMed Google Scholar
• Virtanen, S. M. et al. Age at introduction of new foods and advanced beta cell autoimmunity in young children with HLA-conferred susceptibility to type 1 diabetes. Diabetologia 49, 1512–1521 (2006)
  Article CAS PubMed Google Scholar
• Akerblom, H. K. et al. Dietary manipulation of beta cell autoimmunity in infants at increased risk of type 1 diabetes: a pilot study. Diabetologia 48, 829–837 (2005)
  Article CAS PubMed Google Scholar
• Norris, J. M. et al. Omega-3 polyunsaturated fatty acid intake and islet autoimmunity in children at increased risk for type 1 diabetes. J. Am. Med. Assoc. 298, 1420–1428 (2007)
  Article CAS Google Scholar
• Jun, H. S. & Yoon, J. W. A new look at viruses in type 1 diabetes. ILAR J. 45, 349–374 (2004)
  Article CAS Google Scholar
• Richardson, S. J. et al. The prevalence of enteroviral capsid protein vp1 immunostaining in pancreatic islets in human type 1 diabetes. Diabetologia 52, 1143–1151 (2009)
  Article CAS PubMed Google Scholar
• Nejentsev, S. et al. Rare variants of IFIH1, a gene implicated in antiviral responses, protect against type 1 diabetes. Science 324, 387–389 (2009)
  Article ADS CAS PubMed PubMed Central Google Scholar
• Bougneres, P. F. et al. Factors associated with early remission of type I diabetes in children treated with cyclosporine. N. Engl. J. Med. 318, 663–670 (1988)
  Article CAS PubMed Google Scholar
• Stiller, C. R. et al. Effects of cyclosporine immunosuppression in insulin-dependent diabetes mellitus of recent onset. Science 223, 1362–1367 (1984)
  Article ADS CAS PubMed Google Scholar
• Feutren, G. et al. Cyclosporin increases the rate and length of remissions in insulin dependent diabetes of recent onset. Results of a multicentre double-blind trial. Lancet 2, 119–124 (1986)
  Article CAS PubMed Google Scholar
• Eisenbarth, G. S. et al. Anti-thymocyte globulin and prednisone immunotherapy of recent onset type I diabetes mellitus. Diabetes Res. 2, 271–276 (1985)
  CAS PubMed Google Scholar
• Allen, H. F. et al. Effect of BCG vaccination on new-onset insulin-dependent diabetes mellitus: a randomized clinical study. Diabetes Care 22, 1703–1707 (1998)
  Article Google Scholar
• Herold, K. C. et al. Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus. N. Engl. J. Med. 346, 1692–1698 (2002)
  Article CAS PubMed Google Scholar
• Keymeulen, B. Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes. N. Engl. J. Med. 352, 2598–2608 (2005)
  Article CAS PubMed Google Scholar
• Herold, K. C. et al. Treatment of patients with new onset type 1 diabetes with a single course of anti-CD3 mAb teplizumab preserves insulin production for up to 5 years. Clin. Immunol. 132, 166–173 (2009)
  Article CAS PubMed PubMed Central Google Scholar
• Chatenoud, L. & Bluestone, J. A. CD3-specific antibodies: a portal to the treatment of autoimmunity. Nature Rev. Immunol. 7, 622–632 (2007)
  Article CAS Google Scholar
• Bisikirska, B. et al. TCR stimulation with modified anti-CD3 mAb expands CD8 T cell population and induces CD8 CD25 Tregs. J. Clin. Invest. 115, 2904–2913 (2005)
  Article CAS PubMed PubMed Central Google Scholar
• Hu, C. Y. et al. Treatment with CD20-specific antibody prevents and reverses autoimmune diabetes in mice. J. Clin. Invest. 117, 3857–3867 (2007)
  Article CAS PubMed PubMed Central Google Scholar
• Bouaziz, J. D., Yanaba, K. & Tedder, T. F. Regulatory B cells as inhibitors of immune responses and inflammation. Immunol. Rev. 224, 201–214 (2008)
  Article CAS PubMed Google Scholar
• Pescovitz, M. D. et al. Rituxan, B-lymphocyte depletion, and preservation of beta-cell function. N. Engl. J. Med. 361, 2143–2152 (2009)
  Article CAS PubMed PubMed Central Google Scholar
• Wise, M. et al. CD4 T cells can reject major histocompatibility complex class I-incompatible skin grafts. Eur. J. Immunol. 29, 156–167 (1999)
  Article CAS PubMed Google Scholar
• Homann, D. et al. Autoreactive CD4+ T cells protect from autoimmune diabetes via bystander suppression using the IL-4/Stat6 pathway. Immunity 11, 463–472 (1999)
  Article CAS PubMed Google Scholar
• Masteller, E. L. et al. Expansion of functional endogenous antigen-specific CD4+CD25+ regulatory T cells from nonobese diabetic mice. J. Immunol. 175, 3053–3059 (2005)
  Article CAS PubMed Google Scholar
• Qin, S. et al. ‘Infectious’ transplantation tolerance. Science 259, 974–977 (1993)
  Article ADS CAS PubMed Google Scholar
• Waldmann, H. & Cobbold, S. How do monoclonal antibodies induce tolerance? A role for infectious tolerance? Annu. Rev. Immunol. 16, 619–644 (1998)
  Article CAS PubMed Google Scholar
• Tang, Q. et al. In vitro expanded antigen-specific regulatory T cells suppress autoimmune diabetes. J. Exp. Med. 199, 1455–1465 (2004)
  Article CAS PubMed PubMed Central Google Scholar
• Skyler, J. S. et al. Effects of oral insulin in relatives of patients with type 1 diabetes: the Diabetes Prevention Trial—Type 1. Diabetes Care 28, 1068–1076 (2005)
  Article CAS PubMed Google Scholar
• Ludvigsson, J. et al. GAD treatment and insulin secretion in recent-onset type 1 diabetes. N. Engl. J. Med. 359, 1909–1920 (2008)
  Article CAS PubMed Google Scholar
• Levings, M. K., Sangregorio, R. & Roncarolo, M. G. Human CD25(+)CD4(+) T regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function. J. Exp. Med. 193, 1295–1302 (2001)
  Article CAS PubMed PubMed Central Google Scholar
• Strom, T. B. & Koulmanda, M. Cytokine related therapies for autoimmune disease. Curr. Opin. Immunol. 20, 676–681 (2008)
  Article CAS PubMed PubMed Central Google Scholar
• Koulmanda, M. et al. Curative and beta cell regenerative effects of α1-antitrypsin treatment in autoimmune diabetic NOD mice. Proc. Natl Acad. Sci. USA 105, 16242–16247 (2008)
  Article ADS CAS PubMed PubMed Central Google Scholar
• Louvet, C. et al. Tyrosine kinase inhibitors reverse type 1 diabetes in nonobese diabetic mice. Proc. Natl Acad. Sci. USA 105, 18895–18900 (2008)
  Article ADS CAS PubMed PubMed Central Google Scholar
• Couri, C. E. & Voltarelli, J. C. Stem cell therapy for type 1 diabetes mellitus: a review of recent clinical trials. Diabetol. Metabol. Syndr. 1, 1–19 (2009)
  Article CAS Google Scholar
• Bresson, D. et al. Anti-CD3 and nasal proinsulin combination therapy enhances remission from recent-onset autoimmune diabetes by inducing Tregs. J. Clin. Invest. 116, 1371–1381 (2006)
  Article CAS PubMed PubMed Central Google Scholar
• Suarez-Pinzon, W. L. et al. Combination therapy with epidermal growth factor and gastrin increases beta-cell mass and reverses hyperglycemia in diabetic NOD mice. Diabetes 54, 2596–2601 (2005)
  Article CAS PubMed Google Scholar
• Matthews, J. B. et al. Developing combination immunotherapies for type 1 diabetes: recommendations from the ITN-JDRF Type 1 Diabetes Combination Therapy Assessment Group. Clin. Exp. Immunol. 10.1111/j.1365–2249.2010.04153.x (in the press)
• Skyler, J. S. et al. Effects of oral insulin in relatives of patients with type 1 diabetes: The Diabetes Prevention Trial--Type 1. Diabetes Care 28, 1068–1075 (2005)
  Article CAS PubMed Google Scholar
• Herold, K. C. et al. A single course of anti-CD3 monoclonal antibody hOKT3γ1(Ala-Ala) results in improvement in C-peptide responses and clinical parameters for at least 2 years after onset of Type 1 diabetes. Diabetes 54, 1763–1769 (2005)
  Article CAS PubMed PubMed Central Google Scholar
• Wong, F. S. et al. Investigation of the role of β-cells in type 1 diabetes in the NOD mouse. Diabetes 53, 2581–2587 (2004)
  Article CAS PubMed Google Scholar